Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition

Gut

Volumn 60, Issue 8, 2011, Pages 1094-1102

  Van Duijnhoven, Fränzel J B ^a,b   Bueno De Mesquita, H Bas ^a,b   Calligaro, Miriam ^a   Jenab, Mazda ^c   Pischon, Tobias ^d   Jansen, Eugène H J M ^a   Frohlich, Jiri ^e   Ayyobi, Amir ^e   Overvad, Kim ^f,g   Toft Petersen, Anne Pernille ^g   Tjønneland, Anne ^h   Hansen, Louise ^h   Boutron Ruault, Marie Christine ⁱ   Clavel Chapelon, Françoise ⁱ   Cottet, Vanessa ⁱ   Palli, Domenico ^j   Tagliabue, Giovanna ^k   Panico, Salvatore ^l   Tumino, Rosario ^m   Vineis, Paolo ^n,o   Kaaks, Rudolf ^p   Teucher, Birgit ^p   Boeing, Heiner ^d   Drogan, Dagmar ^d   Trichopoulou, Antonia ^q,r   Lagiou, Pagona ^q   Dilis, Vardis ^r   Peeters, Petra H M ^b,o   Siersema, Peter D ^b   Rodríguez, Laudina ^s   González, Carlos A ^t   Molina Montes, Esther ^u,v   Dorronsoro, Miren ^w   Tormo, Maria Jose ^v,x   Barricarte, Aurelio ^v,y   Palmqvist, Richard ^z   Hallmans, Göran ^z   Khaw, Kay Tee ^aa   Tsilidis, Kostas K ^ab   Crowe, Francesca L ^ab   Chajes, Veronique ^c   Fedirko, Veronika ^c   Rinaldi, Sabina ^c   Norat, Teresa ^o   Riboli, Elio ^o   more..

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f AARHUS UNIVERSITY   (Denmark)

^g AALBORG UNIVERSITY HOSPITAL   (Denmark)

^h INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

ⁱ CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^j CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^k NATIONAL CANCER INSTITUTE   (Italy)

^l UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^m CIVILE M P AREZZO HOSPITAL   (Italy)

ⁿ HuGeF Foundation   (Italy)

^o IMPERIAL COLLEGE LONDON   (United Kingdom)

^p GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^q UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^r HELLENIC HEALTH FOUNDATION   (Greece)

^s Health and Health Care Services Council   (Spain)

^t CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^u Andalusia School of Public Health   (Spain)

^v CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^w Department of Public Health of Guipuzkoa ^*  (Spain)

^x DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^y INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^z UMEÅ UNIVERSITY   (Sweden)

^aa UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ab UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; CANCER CENTER; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COLORECTAL CANCER; COLORIMETRY; CONTROLLED STUDY; DIET; DIET RESTRICTION; DIETARY FIBER; EDUCATION; ENERGY CONSUMPTION; FEMALE; FISH; FOLLOW UP; FOOD INTAKE; FRUIT; GENDER; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEAT; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; SMOKING HABIT; TURBIDIMETRY; VEGETABLE; WESTERN EUROPE;

AGED; BODY MASS INDEX; COLORECTAL NEOPLASMS; COLORIMETRY; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; NUTRITION SURVEYS; PATIENT EDUCATION AS TOPIC; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79960301171     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.225011     Document Type: Article

References (43)

1. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 2007;86:s836-42.
2. Chung YW, Han DS, Park YK, et al. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis 2006;38:668-72. (Pubitemid 44356269)
3. Jarvinen R, Knekt P, Hakulinen T, et al. Dietary fat, cholesterol and colorectal cancer in a prospective study. Br J Cancer 2001;85:357-61. (Pubitemid 32747702)
4. Tornberg SA, Holm LE, Carstensen JM, et al. Risks of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein. N Engl J Med 1986;315:1629-33. (Pubitemid 17052894)
5. Schatzkin A, Hoover RN, Taylor PR, et al. Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic follow-up study. Cancer Res 1988;48:452-8. (Pubitemid 18045786)
6. Ahmed RL, Schmitz KH, Anderson KE, et al. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006;107:28-36. (Pubitemid 43941640)
7. Schoen RE, Tangen CM, Kuller LH, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999;91:1147-54. (Pubitemid 29330553)
8. Tsushima M, Nomura AM, Lee J, et al. Prospective study of the association of serum triglyceride and glucose with colorectal cancer. Dig Dis Sci 2005;50:499-505. (Pubitemid 40543738)
9. Ulmer H, Borena W, Rapp K, et al. Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer 2009;101:1202-6.
10. Esteve E, Ricart W, Fernandez-Real JM. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 2005;24:16-31.
11. Avramoglu RK, Basciano H, Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 2006;368:1-19. (Pubitemid 43776015)
12. Kontush A, de Faria EC, Chantepie S, et al. A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis 2005;182:277-85. (Pubitemid 41267195)
13. Vekic J, Kotur-Stevuljevic J, Jelic-Ivanovic Z, et al. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects. Eur J Clin Invest 2007;37:715-23. (Pubitemid 47256172)
14. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989;298:784-8. (Pubitemid 19084522)
15. Lee SA, Wen W, Xiang YB, et al. Stability and reliability of plasma level of lipid biomarkers and their correlation with dietary fat intake. Dis Markers 2008;24:73-9.
16. Hardman AE. Interaction of physical activity and diet: implications for lipoprotein metabolism. Public Health Nutr 1999;2:369-76. (Pubitemid 29529014)
17. Kasim-Karakas SE, Almario RU, Mueller WM, et al. Changes in plasma lipoproteins during low-fat, high-carbohydrate diets: effects of energy intake. Am J Clin Nutr 2000;71:1439-47. (Pubitemid 30395889)
18. Frohlich JJ. Effects of alcohol on plasma lipoprotein metabolism. Clin Chim Acta 1996;246:39-49. (Pubitemid 26096381)
19. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26(Suppl 1):S6-14.
20. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24. (Pubitemid 36313608)
21. Verheus M, Peeters PH, Rinaldi S, et al. Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2006;119:659-67. (Pubitemid 43955721)
22. Kaaks R, Berrino F, Key T, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005;97:755-65.
23. Al-Delaimy WK, Jansen EH, Peeters PH, et al. Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 2006;11:370-82.
24. Aleksandrova K, Jenab M, Boeing H, et al. Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. Am J Epidemiol 2010;172:407-18.
25. Jenab M, Riboli E, Cleveland RJ, et al. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007;121:368-76. (Pubitemid 46917707)
26. Rinaldi S, Rohrmann S, Jenab M, et al. Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2008;17:3108-15.
27. Knol MJ, Vandenbroucke JP, Scott P, et al. What do case-control studies estimate? Survey of methods and assumptions in published case-control research. Am J Epidemiol 2008;168:1073-81.
28. Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoBlipoprotein- depleted plasma (FER(HDL)). Clin Biochem 2001;34:583-8.
29. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003;6:407-13. (Pubitemid 36749764)
30. Alberti KG, Zimmet P, Shaw J. Metabolic syndromeea new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-80.
31. Ahn J, Lim U, Weinstein SJ, et al. Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev 2009;18:2814-21.
32. Potter JD. Nutrition and colorectal cancer. Cancer Causes Control 1996;7:127-46. (Pubitemid 26066852)
33. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002;101:403-8.
34. Sugai T, Habano W, Jiao YF, et al. Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. J Mol Diagn 2006;8:193-201. (Pubitemid 43811242)
35. Azzoni C, Bottarelli L, Campanini N, et al. Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. Int J Colorectal Dis 2007;22:115-26. (Pubitemid 44964014)
36. Wei EK, Giovannucci E, Wu K, et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer 2004;108:433-42. (Pubitemid 37549610)
37. Kim S, Keku TO, Martin C, et al. Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res 2008;68:323-8. (Pubitemid 351380135)
38. van Exel E, Gussekloo J, de Craen AJ, et al. Low production capacity of interleukin- 10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study. Diabetes 2002;51:1088-92. (Pubitemid 34438354)
39. Napoli C, de Nigris F, Palinski W. Multiple role of reactive oxygen species in the arterial wall. J Cell Biochem 2001;82:674-82. (Pubitemid 32720682)
40. Valko M, Izakovic M, Mazur M, et al. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004;266:37-56. (Pubitemid 39562306)
41. Trevisan M, Liu J, Muti P, et al. Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 2001;10:937-41. (Pubitemid 32844900)
42. Poynter JN, Gruber SB, Higgins PD, et al. Statins and the risk of colorectal cancer. N Engl J Med 2005;352:2184-92. (Pubitemid 40727085)
43. Cole BF, Logan RF, Halabi S, et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 2009;101:256-66.